Search Knowledge Base

31 results for "heparin"

Regional Citrate Anticoagulation or Heparin Anticoagulation for Renal Replacement Therapy in Patients With Liver Failure: A Systematic Review and Meta-Analysis pubmed_article
Evidence Source 2023 PMID: 37186766
Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair pubmed_article
Evidence Source 2025 PMID: 39868562
Safety and efficacy of apixaban versus low-molecular weight heparin or vitamin-K antagonists for venous thromboembolism treatment in patients with severe renal failure: A systematic review and meta-analysis pubmed_article
Evidence Source 2023 PMID: 37419006
Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism pubmed_article
Evidence Source 2017 PMID: 28737834
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism pubmed_article
Evidence Source 2012 PMID: 23076894
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism pubmed_article
Evidence Source 2002 PMID: 11869618
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism pubmed_article
Evidence Source 2000 PMID: 11034739
Perioperative Management of Vitamin K Antagonists and Direct Oral Anticoagulants: A Systematic Review and Meta-analysis pubmed_article
Evidence Source 2023 PMID: 36462533
Safety and efficacy of Direct Oral Anticoagulants in cerebral venous thrombosis: A meta-analysis pubmed_article
Evidence Source 2022 PMID: 34287841
Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents pubmed_article
Evidence Source 2021 PMID: 34582035
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation pubmed_article
Evidence Source 2021 PMID: 34622445
Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity pubmed_article
Evidence Source 2020 PMID: 32692430
Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity pubmed_article
Evidence Source 2013 PMID: 24343728
Anticoagulation for patients with cancer and central venous catheters pubmed_article
Evidence Source 2011 PMID: 21328283
Anticoagulation for patients with cancer and central venous catheters pubmed_article
Evidence Source 2011 PMID: 21491394
Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters pubmed_article
Evidence Source 2007 PMID: 17636845
Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates pubmed_article
Evidence Source 2012 PMID: 22912386
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement pubmed_article
Evidence Source 2010 PMID: 20393944
Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial. unknown
wiki/source/pmid-33095849
Understanding 'Heparin Resistance' in Cardiac Surgery unknown
wiki/sources/nct-nct01598883
Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial. unknown
wiki/sources/pmid-33095849
Anticoagulants for people hospitalised with COVID-19 pubmed_article
Evidence Source 2022 PMID: 35244208
Network meta-analysis of anticoagulation strategies for venous thromboembolism in patients with cancer pubmed_article
Evidence Source 2021 PMID: 32458316
Anticoagulant selection for patients with VTE-Evidence from a systematic literature review of network meta-analyses pubmed_article
Evidence Source 2019 PMID: 30905806
Pentasaccharides for the treatment of deep vein thrombosis pubmed_article
Evidence Source 2017 PMID: 29199766
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair pubmed_article
Evidence Source 2016 PMID: 27027384
Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery pubmed_article
Evidence Source 2015 PMID: 26091835
Systematic review with meta-analysis: the risk of major gastrointestinal bleeding with non-vitamin K antagonist oral anticoagulants pubmed_article
Evidence Source 2015 PMID: 26434935
Anticoagulation for people with cancer and central venous catheters pubmed_article
Evidence Source 2014 PMID: 25318061
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer pubmed_article
Evidence Source 2011 PMID: 21678361

Evidence Search Results semantic · quality-ranked

Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair meta_analysis pubmed_article
Quality: 77 2025 PMID: 39868562 DOI: 10.1002/14651858.CD011762.pub2
Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism meta_analysis pubmed_article
Quality: 71 2017 PMID: 28737834 DOI: 10.1002/14651858.CD002001.pub3
Safety and efficacy of apixaban versus low-molecular weight heparin or vitamin-K antagonists for venous thromboembolism treatment in patients with severe renal failure: A systematic review and meta-analysis meta_analysis pubmed_article
Quality: 55 2023 PMID: 37419006 DOI: 10.1016/j.thromres.2023.06.027
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism meta_analysis pubmed_article
Quality: 71 2012 PMID: 23076894 DOI: 10.1002/14651858.CD002001.pub2
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement meta_analysis pubmed_article
Quality: 73 2010 PMID: 20393944 DOI: 10.1002/14651858.CD005981.pub2
Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates meta_analysis pubmed_article
Quality: 51 2012 PMID: 22912386
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism systematic_review pubmed_article
Quality: 53 2000 PMID: 11034739
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism systematic_review pubmed_article
Quality: 51 2002 PMID: 11869618
Regional Citrate Anticoagulation or Heparin Anticoagulation for Renal Replacement Therapy in Patients With Liver Failure: A Systematic Review and Meta-Analysis meta_analysis pubmed_article
Quality: 61 2023 PMID: 37186766 DOI: 10.1177/10760296231174001
**Qi et al., 2023** | Clin Appl Thromb Hemost | Meta Analysis Qi Wenqian, Liu Jingyuan, Li Ang. Regional Citrate Anticoagulation or Heparin Anticoagulation for Renal Replacement Therapy in Patients Wi...
Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer meta_analysis pubmed_article
Quality: 74 2018 PMID: 29920657 DOI: 10.1002/14651858.CD006650.pub5

View full evidence search →